Paul A. Volberding
Impact in
- Virology top 0.02%
- HIV Research and Treatment
- Infectious Diseases top 0.01%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS Research and Interventions 63
- HIV/AIDS drug development and treatment 59
- Virology 38
- HIV Research and Treatment 38
- Co-authors
- Douglas D. Richman (14 shared papers)Margaret A. Fischl (14 shared papers)Donna M. Jacobsen (17 shared papers)Melanie Thompson (14 shared papers)Robert T. Schooley (9 shared papers)Scott M. Hammer (9 shared papers)Michael S. Saag (18 shared papers)Martin Hirsch (11 shared papers)
- Journals
- JAMA (20 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (10 papers)The Journal of Infectious Diseases (9 papers)New England Journal of Medicine (9 papers)AIDS (7 papers)
- Partner nations
- United StatesFranceAustralia
In The Last Decade
Paul A. Volberding
186 papers receiving 18.9k citations
Paul A. Volberding's Hit Papers
Peers
Comparison fields: 5 of 176
- Virology 7.3k
- Infectious Diseases 11.4k
- Emergency Medicine 2.2k
- Hepatology 1.4k
- Epidemiology 4.4k
Countries citing papers authored by Paul A. Volberding
This map shows the geographic impact of Paul A. Volberding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Volberding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Volberding more than expected).
Fields of papers citing papers by Paul A. Volberding
This network shows the impact of papers produced by Paul A. Volberding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Volberding. The network helps show where Paul A. Volberding may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul A. Volberding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 191 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex Hit paper breakdown → | 1987 | 2315 |
| 2 | Antiretroviral Treatment of Adult HIV Infection Hit paper breakdown → | 2012 | 1364 |
| 3 | The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex Hit paper breakdown → | 1987 | 977 |
| 4 | Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection Hit paper breakdown → | 1990 | 950 |
| 5 | Antiretroviral Therapy in Adults Hit paper breakdown → | 2000 | 874 |
| 6 | Antiretroviral Therapy for HIV Infection in 1998 Hit paper breakdown → | 1998 | 837 |
| 7 | Antiretroviral Treatment of Adult HIV Infection Hit paper breakdown → | 2008 | 834 |
| 8 | Treatment for Adult HIV Infection Hit paper breakdown → | 2006 | 764 |
| 9 | Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected Persons Hit paper breakdown → | 2004 | 674 |
| 10 | Treatment for Adult HIV Infection Hit paper breakdown → | 2004 | 599 |
| 11 | Antiretroviral Treatment of Adult HIV Infection Hit paper breakdown → | 2010 | 595 |
| 12 | Antiretroviral Treatment for Adult HIV Infection in 2002 Hit paper breakdown → | 2002 | 571 |
| 13 | Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults Hit paper breakdown → | 2016 | 483 |
| 14 | Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults Hit paper breakdown → | 2018 | 403 |
| 15 | 1996 | 394 | |
| 16 | Antiretroviral Treatment of Adult HIV Infection Hit paper breakdown → | 2014 | 355 |
| 17 | 2010 | 320 | |
| 18 | 2020 | 312 | |
| 19 | 1996 | 296 | |
| 20 | Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. | 2006 | 258 |
About Paul A. Volberding
Paul A. Volberding is a scholar working on Infectious Diseases, Virology, Epidemiology, Oncology and Immunology, having authored 191 papers that have together received 19.8k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (63 papers), HIV/AIDS drug development and treatment (59 papers), HIV Research and Treatment (38 papers), Viral-associated cancers and disorders (26 papers), HIV-related health complications and treatments (20 papers), Pneumocystis jirovecii pneumonia detection and treatment (18 papers), Lymphoma Diagnosis and Treatment (12 papers) and Immunodeficiency and Autoimmune Disorders (10 papers). The work is most often cited by research in Virology (7.3k citations), Infectious Diseases (11.4k citations), Emergency Medicine (2.2k citations), Hepatology (1.4k citations) and Epidemiology (4.4k citations). Paul A. Volberding has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Douglas D. Richman, Margaret A. Fischl, Donna M. Jacobsen, Melanie Thompson, Robert T. Schooley, Scott M. Hammer, Michael S. Saag, Martin Hirsch, Patrick Yéni and Joseph J. Eron. Their work appears in journals such as JAMA, JAIDS Journal of Acquired Immune Deficiency Syndromes, The Journal of Infectious Diseases, New England Journal of Medicine and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.